News and Trends 28 Apr 2023
Mezzion Pharma raises $40M for treatment option for heart surgery patients
Mezzion Pharma, a rare disease focused pharmaceutical company, has secured nearly $40 million to fund FUEL-2, its confirmatory phase 3 clinical trial, along with future commercialization and regulatory submissions in…